Active Pharmaceuticals Ingredients apollo api ,Indian Manufacturer,Indian API Exporter,Indian,Supplier,Pharmaceutical API,ACTIVE PHARMACEUTICAL INGREDIENTS in India, API Manufacturing India, API Exporter India, Domestic API Manufacturer, Pharmaceuticals Exporter India, API Manufacturer India, Benzyl acetone exporter,benzyl acetone manufacturer,benzyl methyl ketone supplier Indian API Manufacturer, Indian API Manufacturer, Indian API Manufacturing, Chloroquine Phosphate API Manufacturer India, Digoxin API Manufacturer India, Ergometrine API Manufacturing India, Gentamicin API Manufacturing India, Hydroxocobalmin API Manufacturing India, Isoprenaline API Manufacturing India, Pharmaceutical Formulations Manufacturer India, Contract Manufacturing Pharmaceuticals API, Pharmaceutical API Formulations Manufacturer, apollo api Pharmaceuticals Limited

Download Brochure


PRODUCT
                                                                                                               
Apollo Pharmaceuticals API Manufacturers India Pvt.Ltd.
is committed to our customers and employees and, more importantly, to the people who rely on our medicines. We plan to move forward with greater vigour and a clearer vision to put each and every individual at the heart of our commitment, working for healthier India health. With the creation of Apollo Pharmaceuticals Limited, we now have access to one of the richest and most innovative research pipelines in the pharmaceutical industry. We're building on our history of hard

.
.
work, diligence and success,tirelessly to enhance the value weare committed to provide towards improving health and the quality of lives across the world. Quality has always been a strong part of Apollo Pharmaceuticals proposition. Care is taken to ensure a high level of quality in our products and services.

Indian pharma industry is set to defy recession by registering a 20% growth in exports during the current fiscal. As per projections made by Centre for Monitoring Indian Economy pharma exports from India is expected to touch the figure of Rs30,500 crore in 2010-2011 against the exports of Rs20,000 crore in the previous year. Depreciation in Indian rupee and cost advantage will help the industry to post such an exponential growth in overseas sales. The forecast seems quite optimistic, as the industry posted just 10% growth in export in 2010-2011 compared to Rs26,000 crore recorded in 2008-2009. However, depreciation in Indian currency is going to help them in a big way to achieve the growth. In the first half of the current fiscal, rupee depreciated by whopping 6.6% against the dollar and the trend is likely to continue till the end of the fiscal. India's export of drugs and pharmaceuticals accounts for almost 45% of the sectors' aggregate sales.


"Global recession is not expected to impact Indian pharma sector due to its low cost manufacturing advantage. Indian companies are mostly into the manufacturing of generic drugs and offers drugs at a price much lower than the patent holder company. In fact, slowdown will prove to be a boon forIndian pharma companies, as foreign customers will look for cheaper products. However, growth of exports may slowdown in last two quarters," says Sarabjeet Kaur, vice president, research-pharmaceuticals, Angel Broking. "The first two quarters have been good for pharma sector and no significant impact of slowdown was visible